Medpace boosts buyback by $60M; retired 1.6M shares (~5% of float) in past month

Medpace Holdings, Inc.

Board approved $60M increase to existing stock repurchase program on May 25, 2022.
From Apr 22 to May 25, 2022, repurchased 1,597,007 shares for treasury.
Repurchases reduced outstanding shares by approximately 5% to 32,065,701 as of May 25.
Timing and volume of future repurchases depend on market conditions and securities laws.
Program may be discontinued or amended at any time without notice.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.